Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Pediatrics|May 9, 2007
Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trialElena Pope, Bernice R Krafchik, Colin Macarthur, et al.
Journal of Pediatric Hematology/Oncology|August 6, 2010
The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1Benjamin Gesundheit, Patricia Parkin, Mark Greenberg, et al.
Cancer Chemotherapy and Pharmacology|July 10, 2019
Population pharmacokinetics of trabectedin in adolescent patients with cancerItalo Poggesi, Belén Valenzuela, Daniele Ouellet, et al.
Translational Oncology|August 3, 2013
Tumor dynamics in response to antiangiogenic therapy with oral metronomic topotecan and pazopanib in neuroblastoma xenograftsSushil Kumar, Reza Bayat Mokhtari, Indhira Dias Oliveira, et al.
European Journal of Haematology|November 6, 2009
Kasabach-Merritt phenomenon: a single centre experienceClodagh Ryan, Vicotria Price, Philip John, et al.
Pediatric Blood & Cancer|November 16, 2012
Successful liver transplantation in an infant with stage 4S(M) neuroblastomaMelanie Steele, Nicola L Jones, Vicky Ng, et al.
Pediatric Blood & Cancer|February 21, 2019
Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumorsDonna L Johnston, Susan Zupanec, Darcy Nicksy, et al.
Neoplasia (New York, N.Y.)|September 25, 2008
Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growthBikul Das, Roula Antoon, Rika Tsuchida, et al.
Pediatric Blood & Cancer|July 30, 2013
A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortiumAlexandra P Zorzi, Mark Bernstein, Yvan Samson, et al.
Journal of Pediatric Hematology/Oncology|November 27, 2013
Metachronous neuroblastoma in an infant with germline translocation resulting in partial trisomy 2p: a role for ALK?Daniel A Morgenstern, Shui Yen Soh, Dimitri J Stavropoulos, et al.
Pageof 8